DE161621C - - Google Patents
Info
- Publication number
- DE161621C DE161621C DENDAT161621D DE161621DA DE161621C DE 161621 C DE161621 C DE 161621C DE NDAT161621 D DENDAT161621 D DE NDAT161621D DE 161621D A DE161621D A DE 161621DA DE 161621 C DE161621 C DE 161621C
- Authority
- DE
- Germany
- Prior art keywords
- fatigue
- toxin
- animals
- antitoxin
- toxins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003053 toxin Substances 0.000 claims description 28
- 231100000765 toxin Toxicity 0.000 claims description 28
- 108700012359 toxins Proteins 0.000 claims description 28
- 230000001147 anti-toxic effect Effects 0.000 claims description 21
- 241001465754 Metazoa Species 0.000 claims description 18
- 210000003205 muscle Anatomy 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 210000003608 fece Anatomy 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 230000002929 anti-fatigue Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940045136 urea Drugs 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229960001188 diphtheria antitoxin Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005367 tetanus antitoxin Drugs 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE161621C true DE161621C (en, 2012) |
Family
ID=427479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT161621D Active DE161621C (en, 2012) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE161621C (en, 2012) |
-
0
- DE DENDAT161621D patent/DE161621C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69221872T2 (de) | Verwendung der nichtpigmentierten fischhaut, insbesondere von plattfischen als industrielle herkunft für kollagen. verfahren zur extrahierung, kollagen und biomaterial so erhalten. | |
| DE69103755T2 (de) | Wachstumshormonkristalle und verfahren zu deren herstellung. | |
| DE161621C (en, 2012) | ||
| DE2010788A1 (de) | Wasserunlösliche Substanzen mit Antigenwirkung und Verfahren zu ihrer Herstellung | |
| DE3101001A1 (de) | Verfahren zur konzentration und reinigung des antihaemophilie-faktors oder faktor viii | |
| DE1244337B (de) | Verfahren zur Gewinnung eines tumorhemmenden Proteins | |
| DE2715748B2 (de) | Gereinigte aktive Verbindung des Plasminogen-Typs menschlichen Ursprungs und ihre Verwendung | |
| DE1802386C2 (de) | Verfahren zur Gewinnung von cytobiotischen Globulinen | |
| AT392003B (de) | Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat | |
| DE307975C (en, 2012) | ||
| DE707028C (de) | Verfahren zur Herstellung eines antithyreoidalen Stoffes | |
| AT163871B (de) | Verfahren zur Herstellung eines Heilmittels aus Darmschleimhaut gegen verschiedene allergische Erkrankungen | |
| DE2325196C2 (de) | Verfahren zur Herstellung eines eiweißfreien Extraktes aus hämolysiertem Blut | |
| AT200257B (en, 2012) | ||
| DE700007C (de) | Verfahren zur Herstellung physiologisch wirksamer Stoffe aus Milch oder Molken | |
| AT54778B (de) | Verfahren zur Gewinnung von Immunstoffen. | |
| DE1902590A1 (de) | Serum zur Entwicklung von Immunitaet gegen Antigene bei Menschen und Tieren sowie Verfahren zu seiner Herstellung | |
| DE3837669A1 (de) | Die verwendung koerpereigener fibroblasten und epidermiszellen als wirkstoff-traeger fuer die intrakorporale behandlung und als wirkstoffvermittler fuer die lokalbehandlung | |
| DE673604C (de) | Verfahren zur Herstellung von resorbiergbarer Watte | |
| DE212709C (en, 2012) | ||
| DE1617447C (de) | Verfahren zur Herstellung eines reinen, hochviskosen Hyaluronsaurepraparates | |
| DE124985C (en, 2012) | ||
| DE627743C (de) | Verfahren zur Gewinnung physiologisch wirksamer Substanzen aus Muskeln | |
| AT123529B (de) | Verfahren zur Herstellung von die Tuberkulose verhütenden und heilenden Impfstoffen. | |
| AT136723B (de) | Verfahren zur Steigerung der antianämischen Wirkung der tierischen Leber oder Niere. |